49 9131 84 3385
Secteur d’activité: Medical Devices
Employés à temps plein: 70 100
|Nom||Titre||Payer||Exercé||Année de naissance|
|Dr. Bernhard Montag||Pres, CEO & Chairman of Management Board||3,23M||S.O.||1969|
|Dr. Jochen Schmitz Ph.D.||CFO & Member of Management Board||1,91M||S.O.||1966|
|Ms. Darleen Caron||Chief HR Officer, Labor Director & Member of Management Board||1,61M||S.O.||1964|
|Ms. Elisabeth Staudinger-Leibrecht||Member of Management Board||1,15M||S.O.||1970|
|Mr. Peter Koerte Ph.D.||Chief Technology & Strategy Officer||S.O.||S.O.||S.O.|
|Mr. Marc Koebernick||Head of Investor Relations||S.O.||S.O.||S.O.|
|Dr. Michel Therin D.V.M., Ph.D.||Pres of Advanced Therapies||S.O.||S.O.||1961|
|Christian Klaussner||Exec. VP of Fin.||S.O.||S.O.||S.O.|
|Andre Hartung||Head of Imaging||S.O.||S.O.||S.O.|
|Mr. Christopher A. Toth||Head of Varian||S.O.||S.O.||1979|
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. The Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory, molecular, and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, and solutions and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services and consulting capabilities, and digital solutions and applications for managing treatment and therapy. The Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms, including a robotic-assisted platform for endovascular coronary and peripheral vascular interventions. It also provides equipment performance management, clinical education and e-learning, asset management, and managed departmental services for laboratories and healthcare facilities, as well as consulting and digital health services. Siemens Healthineers AG has a collaboration with Oncimmune Holdings plc. The company is headquartered in Erlangen, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.
L’ISS Governance QualityScore de Siemens Healthineers AG en date du 1 mars 2023 est 4. Les scores principaux sont Audit : 2; Société : 6; Droits des actionnaires : 6; Compensation : 1.